GlassScriptPhysician profile
Keung Ung
NPI 1972640498
$6,807.85
in general payments reported to CMS, 2019-2025
29 companies · $535 in 2025
The $535 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $1,363 · 2021: $1,707 · 2022: $498 · 2023: $1,542 · 2024: $760 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,177 · Travel and Lodging: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,176.65 |
| Travel and Lodging | $660.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,689.08 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $1,014.75 | 2022-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $357.38 | 2020-2024 | Camzyos, Eliquis |
| Getinge USA Sales, LLC | $350.78 | 2022-2024 | Vasoview Hemopro 2 |
| Astrazeneca Pharmaceuticals LP | $309.55 | 2019-2024 | Farxiga, Brilinta, Wainua |
| Edwards Lifesciences Corporation | $291.27 | 2024-2025 | Hemosphere, Sapien 3 Ultra Resilia |
| Artivion, INC. | $248.44 | 2023-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Amgen INC. | $230.49 | 2020-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $197.00 | 2019-2022 | |
| Davol INC. | $160.49 | 2019-2025 | Progel Applicator Spray Tips |
| Medtronic, INC. | $145.42 | 2023-2025 | Corevalve Evolut R, Aquamantys(Tm) |
| Actelion Pharmaceuticals US, INC. | $114.96 | 2019-2023 | Uptravi, Opsumit |
| Zimmer Biomet Holdings, INC. | $105.39 | 2021-2024 | Sternalock Blu System |
| La Jolla Pharmaceutical Company | $74.25 | 2022-2025 | Giapreza |
| Amarin Pharma, INC. | $73.86 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $66.19 | 2019-2021 | |
| Haemonetics Corporation | $64.86 | 2024 | Teg6s Hemostasis System |
| Bayer Healthcare Pharmaceuticals INC. | $38.64 | 2025 | |
| Becton, Dickinson and Company | $33.96 | 2024 | Progel Applicator Spray Tips |
| Smith+Nephew, INC. | $33.70 | 2024 | Stravix |
| Ethicon US, LLC | $32.22 | 2023-2024 | Ethicon, Evarrest, Stratafix |
| Philips North America LLC | $27.77 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Chiesi USA, INC. | $27.29 | 2021 | |
| Lsi Solutions INC | $25.91 | 2024 | Cor-Knot |
| Abbott Laboratories | $24.82 | 2020 | |
| Convatec INC. | $24.33 | 2025 | |
| Pfizer INC. | $22.52 | 2022 | |
| Daiichi Sankyo INC. | $18.45 | 2023 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keung Ung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.